Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117034) titled 'Studies on the Use of Ceftazidime-Avibactam Alone or in Combination for the Treatment of Multidrug-Resistant Bacterial Infections' on Jan. 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The first people's Hospital of Yunnan Province
Condition:
CRO infection
Intervention:
Combination Group:Ceftazidime-Avibactam-Based Combination Regimens with Other Antibacterial Agents
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-02-01
Target Sample Size: Combination Group:126;Monotherapy group:126;
Countries of Recruitment:
China
To know more, visit https...